Although functionally compromised p53 mutations are prevalent in more than half of human cancers (Bykov et al., 2018; Hollstein et al., 1991), specific p53 isoforms have recently been associated with tumorigenesis in various cancer types (Vieler and Sanyal, 2018; Zhao and Sanyal, 2022). This evidence concerns the gene TP53 and cancer.